Company / Gross Profit
Phathom Pharmaceuticals, Inc. Gross Profit History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$152.5M
FY2025
5-year range
$0 / $152.5M
FY2022-FY2025
Trend
+29513.8%
vs FY2024
Sector context
#24 of 29
Health Care
What the data says
Gross Profit changed +29514% YoY in FY2025, a notable deviation from the 2-year average annual change of +14757%.
Based on SEC 10-K filings.
$153M in FY2025.
Improved from $515,000 to $153M over the past 2 years.
Health Care sector context is included.
Gross Profit over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 29This company $152.5M Sector average $3.5B
▼
-95.6% below sector average
Key checks
Key Insights
- In FY2025, gross profit increased 29513.8% year-over-year.
- Ranks #24 out of 29 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $152.5M | +29513.8% |
| FY2024 | $515.0K | +0.0% |
| FY2023 | $515.0K | - |
| FY2022 | $0 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026